sifin diagnostics gmbh

sifin diagnostics gmbh develops, manufactures, distributes and trades diagnostics and components for human diagnostics, veterinary diagnostics and food diagnostics as well as culture media for microbiological analysis. The company's core competencies are monoclonal antibodies and culture media; it produces both finished products and intermediate products at various refinement stages. All development and production activities (excluding traded goods) are carried out at a single site in Berlin and the products are offered worldwide in around 80 countries. In fiscal year 2023 the company recorded revenues of EUR 15.16 million and a net profit of EUR 820,387 with an equity ratio of approximately 88.2%.